Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cancer cells ’’commit suicide’’

30.09.2003


Catalysts which cause cancer cells to ’’commit suicide’’ have been developed in the laboratory by West Country scientists.



The research groups of Dr Claus Jacob, of Exeter University and Dr Nicholas Gutowski at the Royal Devon and Exeter Hospital, with support from the Peninsula Medical School, are investigating the anti-cancer effects of biocatalysts that mimic the activity of the human selenium enzyme, glutathione peroxidase. Their work opens up a very promising new direction for anti-cancer research, but both stress that any potential treatment for sufferers is still many years away.

Dr Jacob, of the University’’s School of Biological and Chemical Sciences, explained: ’’The catalysts work by initiating reactions inside the cancer cell that cause it to destroy itself. In effect, the cancer commits
suicide. One of the benefits of this approach is that the drugs target only the diseased cells.


The research opens up the possibility in the future of an entirely new way of treating cancer that has two advantages over conventional treatments:

1. The catalysts use the particular makeup of cancer cells for their activity and thus do not work in healthy cells. This means they are far more targeted than conventional drugs and could potentially avoid many of the unpleasant side effects associated with chemotherapy and radiotherapy.

2. Catalysts are not consumed during their activity but are recycled over and over again. This means that only minute quantities of biocatalyst are needed to kill cancer cells making them highly efficient.

Dr Jacob said: ’’Cancer therapy has long been based on highly toxic substances that randomly kill healthy and sick cells alike. This new approach might allow us to single out sick cells and kill them with a catalytic efficiency far superior to conventional radiation or chemotherapy. The experimental results obtained so far have been truly impressive but further evaluation and clinical trials are required to develop this.’’

The compounds have been developed and synthesised at the University’’s School of Biological and Chemical Sciences and tested in cancer cells at the Royal Devon and Exeter Hospital. The work has been partially funded by the Leverhulme Trust. An Exeter based company has already shown an interest in the compounds and the new method. The most active compound tested so far is a multifunctional catalyst that integrates a quinone with a chalcogen redox system in one chemically simple molecule.

Claus Jacob | alfa

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>